论文部分内容阅读
33例肺癌患者血清皮质醇水平为179.91±121.69ng/ml;54例正常人组104.28±44.23ng/ml,肺癌组显著高于正常人组。18例肺癌恶病质(A组)血清T_3水平为0.63+0.27ng/ml;15例肺癌一般状况好组(B组)血清T_3水平1.47±0.49ng/ml;132例正常人组血清T_3水平1.24±0.40ng/ml。A组明显低于B组及正常人组(P<0.01);B组与正常人组无显著差异。A组血清T_4水平为7.73+3.23μg/dl;B组血清T_48.28±22.4μg/dl;正常人组血清T_49.43±2.64μg/dl,各组之间无显著差异(P>0.05)。本文探讨了肺癌患者血清皮质醇T_3、T_4的临床意义。
The serum cortisol level in 33 patients with lung cancer was 179.91±121.69 ng/ml; 104 normals in 104 patients were 104.28±44.23 ng/ml, and the lung cancer group was significantly higher than the normal group. Eighteen patients with lung cancer cachexia (Group A) had serum T 3 levels of 0.63+0.27 ng/ml; 15 patients with good general conditions of lung cancer (Group B) had serum T 3 levels of 1.47±0.49 ng/ml; and 132 patients of normal subjects had serum T 3 levels of 1.24± 0.40ng/ml. A group was significantly lower than B group and normal group (P <0.01); B group and normal group had no significant difference. Serum T_4 level in group A was 7.73+3.23μg/dl; serum in group B was T_48.28±22.4μg/dl; serum in normal group was T_49.43±2.64μg/dl, with no significant difference between groups (P>0.05) . This article discusses the clinical significance of serum cortisol T_3 and T_4 in patients with lung cancer.